SEC Filings

Document Details

Form
Filing Date
Jan 24, 2019
Document Date
Jan 22, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Aimmune Therapeutics
Issuer
Aimmune Therapeutics, Inc.